P352. Unblinded Results from a dose-escalating placebo-controlled study with allogeneic bone marrow-derived mesenchymal stem cells for the treatment of refractory perianal fistulas in patients with Crohn's disease
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.